EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, HMTXF: Hemostemix Inc

28 Oct 2025
LAST:

0.0691

CHANGE:
 0.00		OPEN:
0.0691		HIGH:
0.0691		ASK:
0.0000		VOLUME:
100
CHG(%):
6.24		PREV:
0.0737		LOW:
0.0691		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Oct 250.06910.06910.06910.0691100
22 Oct 250.07370.07370.07370.07377.8K
20 Oct 250.07270.07270.07270.072710.0K
14 Oct 250.08000.08000.07440.074427.0K
10 Oct 250.07410.07410.07410.0741200
09 Oct 250.08060.08380.08060.08382.9K

COMPANY PROFILE

Name:Hemostemix Inc
About:Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:707-7th Avenue SW, Calgary, AB, Canada, T2P 3H6
Website:https://hemostemix.com
CIK:0001716567
FIGI:BBG00BNK7P48

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.075.4%
MA10:0.0811.0%
MA20:0.0813.5%
MA50:0.0810.0%
MA100:0.0814.6%
MA200:0.0929.5%
STO14:5.56 
RSI14:45.28
WPR14:-93.57 
MTM14:0.00
ROC14:-0.07 
ATR:0.00 
Week High:0.076.7%
Week Low:0.070.0%
Month High:0.0927.1%
Month Low:0.0729.5%
Volatility:151.88 

RECENT SPLITS

Date Ratio
30 Dec 20201-20